IP Library Granted Patent US 6,872,559
Granted Patent B2
US 6,872,559 · App. 10/002,309 · Granted Mar 29, 2005

E. coli O157:H7 C1 esterase inhibitor-binding protein and methods of use

Assignee: Wisconsin Alumni Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,872,559
App. No.
10/002,309
Granted
Mar 29, 2005
Kind
B2
Abstract

Disclosed is a pO157 plasmid-specified polypeptide found in E. coli EDL933and other enterohemorrhagic E. coli that binds to and cleaves C1-esterase inhibitor. Also disclosed are methods employing the polypeptide for diagnosing and treating colitis or hemolytic uremic syndrome, and methods of detecting potential therapeutics.

Claims (11)

1. An isolated polypeptide comprising the amino acid sequence of amino acid sequence of amino acid residues 230-630 of SEQ ID NO:2, wherein the polypeptide comprises a StcE specific immunogen or has the ability to bind to and cleave C1 esterase inhibitor.

2. The polypeptide of claim 1 , wherein the polypeptide comprises amino acid residues 85-734 of SEQ ID NO:2.

3. The polypeptide of claim 1 , wherein the polypeptide comprises amino acid residues 24-886 of SEQ ID NO:2.

4. The polypeptide of claim 1 , wherein the polypeptide has the ability to bind to and cleave C1 esterase inhibitor.

5. An isolated polypeptide comprising an amino acid sequence having at least 95% amino acid identity to amino acid residues 24-886 of SEQ ID NO:2, the polypeptide comprising a sequence corresponding with and identical to amino acids 434-444 of SEQ ID NO:2, the polypeptide having the ability to bind to and cleave C1 esterase inhibitor.

6. An isolated polypeptide, the amino acid sequence of which consists of at least 17 consecutive amino acid residues of SEQ ID NO:2, wherein the polypeptide consists of a StcE specific immunogen.

7. The polypeptide of claim 6 , wherein the amino acid sequence consists of at least 25 consecutive amino acid residues of SEQ ID NO:2.

8. The polypeptide of claim 6 , wherein the amino acid sequence consists of at least 40 consecutive amino acid residues of SEQ ID NO:2.

9. The polypeptide of claim 6 , wherein the amino acid sequence comprises amino acid residues 430-446 of SEQ ID NO:2.

10. The polypeptide of claim 6 , wherein the amino acid sequence comprises amino acid residues 421-446 of SEQ ID NO:2.

11. The polypeptide of claim 6 , wherein the amino acid sequence comprises amino acid residues 408-448 of SEQ ID NO:2.

Assignments (4)
CONFIRMATORY LICENSE Recorded Aug 24, 2018
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 046942/0882 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Dec 1, 2008
From: UNIVERSITY OF WISCONSIN-MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021908/0166 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Dec 1, 2008
From: UNIVERSITY OF WISCONSIN-MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021908/0203 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2002
From: WELCH, RODNEY A.; LATHEM, WYNDHAM W.
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 012750/0044 →
Continuity (2)
Provisional Application 6024367500 · Oct 26, 2000
Related Publication 20020160433A1 · Oct 31, 2002